David Larsen

Stock Analyst at BTIG

(2.77)
# 2,011
Out of 5,040 analysts
80
Total ratings
38.46%
Success rate
0.31%
Average return

Stocks Rated by David Larsen

The Oncology Institute
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $4.69
Upside: +49.25%
Veeva Systems
Oct 17, 2025
Reiterates: Buy
Price Target: $340
Current: $290.54
Upside: +17.02%
Evolent Health
Sep 30, 2025
Reiterates: Buy
Price Target: $20
Current: $7.54
Upside: +165.25%
Cryoport
Sep 18, 2025
Maintains: Buy
Price Target: $10$15
Current: $10.51
Upside: +42.72%
Health Catalyst
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.12
Upside: -
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41$25
Current: $17.41
Upside: +43.60%
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $66.67
Upside: +19.99%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $19.23
Upside: +45.61%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $47.78
Upside: -26.75%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110$130
Current: $96.07
Upside: +35.32%
Maintains: Buy
Price Target: $30$31
Current: $26.63
Upside: +16.41%
Maintains: Buy
Price Target: $290$260
Current: $221.79
Upside: +17.23%
Maintains: Buy
Price Target: $15$20
Current: $33.52
Upside: -40.33%
Maintains: Buy
Price Target: $60$70
Current: $33.20
Upside: +110.84%
Initiates: Buy
Price Target: $7
Current: $2.97
Upside: +136.09%
Maintains: Buy
Price Target: $11$7
Current: $1.28
Upside: +449.02%
Maintains: Buy
Price Target: $13$14
Current: $6.27
Upside: +123.29%
Downgrades: Neutral
Price Target: n/a
Current: $8.74
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $31.09
Upside: -
Initiates: Neutral
Price Target: n/a
Current: $1.00
Upside: -
Initiates: Buy
Price Target: $35
Current: $25.90
Upside: +35.14%
Downgrades: Neutral
Price Target: n/a
Current: $8.53
Upside: -
Initiates: Neutral
Price Target: n/a
Current: $5.53
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $160.45
Upside: -
Maintains: Market Perform
Price Target: $170$160
Current: $799.48
Upside: -79.99%
Upgrades: Outperform
Price Target: n/a
Current: $63.99
Upside: -
Maintains: Outperform
Price Target: $90$85
Current: $81.13
Upside: +4.77%
Maintains: Market Perform
Price Target: $34$23
Current: $5.47
Upside: +320.86%